Results 11 to 20 of about 46,954 (256)

Prevalensi Kuman Multi Drug Resistance (MDR) di Laboratorium Mikrobiologi RSUP Dr. M. Djamil Padang Periode Januari 2010 - Desember 2012

Jurnal Kesehatan Andalas, 2014
AbstrakKuman Multi Drug Resistance (MDR) menyebabkan semakin sulit dalam memilih antibiotika untuk pasien yang mengalami infeksi. Akibat sulitnya pemilihan antibiotika, bisa terjadi perpanjangan masa rawat di Rumah Sakit dan menyebabkan kemunduran dalam ...
Novilla Rezka Sjahjadi, Roslaili Rasyid, Erlina Rustam, Lily Restusari   +3 more
doaj   +3 more sources

Importance of Detection of Isoniazid and Rifampicin Mono Drug Resistance and Determining Rate of MDR-TB in Smear Positive Sputum Samples from a Tertiary Care Hospital of West U.P. India

Journal of Pure and Applied Microbiology, 2019
Anti-tubercular therapy is one of the effective strategies used to control tuberculosis, so, a planned and accurate treatment regimen is of utmost importance, but number of cases are being treated as MDR on the basis of rifampicin mono resistance.
Sana Nudrat, Umar Farooq, Mazhar Maqsood
doaj   +2 more sources

Multi-Drug Resistance Tuberculosis (MDR-TB) Challenges in India: A Review

Cureus, 2023
Tuberculosis (TB) is an increasing public health concern in India. The development of resistance to two of the most effective medications, rifampicin, and isoniazid, is the largest worldwide challenge in the management of TB. An epidemiological indicator used to evaluate the effectiveness of the TB management program is the initial medication ...
Vishwakarma, Deepak, Gaidhane, Abhay, Sahu, Sweta, Rathod, Ashwini S   +3 more
openaire   +2 more sources

High prevalence of multiple antibiotic resistance in clinical E. coli isolates from Bangladesh and prediction of molecular resistance determinants using WGS of an XDR isolate

Scientific Reports, 2021
Multi-drug-resistance (MDR) is a severe public health concern worldwide, and its containment is more challenging in developing countries due to poor antimicrobial resistance (AMR) surveillance and irrational use of antibiotics.
Preeti Jain, Asim Kumar Bepari, Prosengit Kumer Sen, Tanzir Rafe, Rashed Imtiaz, Maqsud Hossain, Hasan Mahmud Reza   +6 more
doaj   +1 more source

In vitro Study of Bedaquiline Resistance in Mycobacterium tuberculosis Multi-Drug Resistant Clinical Isolates

Frontiers in Microbiology, 2020
Tuberculosis (TB) is one of the major causes of death related to antimicrobial resistance worldwide because of the spread of Mycobacterium tuberculosis multi- and extensively drug resistant (multi-drug resistant (MDR) and extensively drug-resistant (XDR),
Giulia Degiacomi, José Camilla Sammartino, José Camilla Sammartino, Virginia Sinigiani, Paola Marra, Alice Urbani, Maria Rosalia Pasca   +6 more
doaj   +1 more source

Multi-drug resistant Pseudomonas aeruginosa: a 2019–2020 single center retrospective case control study

Infection Prevention in Practice, 2023
Summary: Multi-drug resistance in the post COVID-19 world is a growing concern. The objective of this study was to describe temporal trends and explore independent risk factors for the isolation of multi-drug resistant (MDR) P. aeruginosa.
Ann Fan Yang, Vivian Huang, Jevon Samaroo-Campbell, Michael Augenbraun   +3 more
doaj   +1 more source

Isolation and in vitro evaluation of bacteriophages against MDR-bacterial isolates from septic wound infections. [PDF]

PLoS ONE, 2017
Multi-drug resistance has become a major problem for the treatment of pathogenic bacterial infections. The use of bacteriophages is an attractive approach to overcome the problem of drug resistance in several pathogens that cause fatal diseases.
Roja Rani Pallavali, Vijaya Lakshmi Degati, Dakshayani Lomada, Madhava C Reddy, Vijaya Raghava Prasad Durbaka   +4 more
doaj   +1 more source

Programmatically selected multidrug-resistant strains drive the emergence of extensively drug-resistant tuberculosis in South Africa [PDF]

, 2013
South Africa shows one of the highest global burdens of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB). Since 2002, MDR-TB in South Africa has been treated by a standardized combination therapy, which until 2010 included
Pillay, Manormoney, van Helden, Paul D., Nicolaas C. Gey van Pittius (173264), Paul D. van Helden (33594), Marlein E Bosman, Gagneux, Sebastien, Thomas C Victor, Manormoney Pillay (257769), Nicolaas C Gey van Pittius, Borna Müller (173253), Hayes, Cindy, Streicher, Elizabeth M., Andre Trollip (449922), Robin M Warren, Elizabeth M Streicher, Trollip, Andre, Violet N. Chihota (143307), Warren, Robin M., Bosman, Marlein E., Müller, Borna, Violet N Chihota, Cindy Hayes, Marisa Klopper (398815), Cindy Hayes (449923), Elizabeth M. Streicher (439727), Borna Müller, Paul D van Helden, Marlein E. Bosman (449924), Klopper, Marisa, Gerrit Coetzee, Sebastien Gagneux (149824), Chihota, Violet N., Andre Trollip, Marisa Klopper, Sebastien Gagneux, Gerrit Coetzee (296078), Victor, Thomas C., Manormoney Pillay, Coetzee, Gerrit, Gey van Pittius, Nicolaas C., Robin M. Warren (33593), Thomas C. Victor (185348)   +41 more
core   +1 more source

Resistance to the chemosensitizer verapamil in a multi-drug-resistant (MDR) human multiple myeloma cell line [PDF]

International Journal of Cancer, 1996
Inhibitors of P-glycoprotein (P-gp) or chemosensitizers, such as verapamil, are used to reverse multi-drug resistance (MDR) in cancer patients. Clinical studies in patients with myeloma have shown that some patients with P-gp-positive cancer cells respond to the chemosensitizing effect of verapamil. However, this response is short-lived and tumor cells
M R, Abbaszadegan, N E, Foley, M C, Gleason-Guzman, W S, Dalton   +3 more
openaire   +3 more sources

Evaluation of a standardized treatment regimen of anti-tuberculosis drugs for patients with multi-drug-resistant tuberculosis (STREAM) : study protocol for a randomized controlled trial [PDF]

, 2014
Background In contrast to drug-sensitive tuberculosis, the guidelines for the treatment of multi-drug-resistant tuberculosis (MDR-TB) have a very poor evidence base; current recommendations, based on expert opinion, are that patients should be treated ...
Squire, Stephen Bertel, Squire, S Bertel, Patrick PJ Phillips, Madan, Jason, Rusen, I. D., Chiang, Chen-Yuan, Armand Van Deun, Chiang, Chen Yuan, Gabriela Torrea, Phillips, P. (Patrick), Van Deun, Armand, Rusen, ID, Meredith, Sarah K, Jason Madan, Meredith, Sarah K., Nunn, Andrew J, ID Rusen, Nunn, Andrew J., Squire, Bertie, Torrea, Gabriela, Chen-Yuan Chiang, Sarah K Meredith, Phillips, Patrick PJ, Andrew J Nunn, Phillips, Patrick P.J., S Bertel Squire   +25 more
core   +1 more source